NIKKEI 225
39,701.70 +528.55 (+1.35%) HANG SENG
18,062.75 -10.15 (-0.06%) CRUDE OIL
81.06 +0.23 (+0.28%) GOLD FUTURES
2,331.60 +0.80 (+0.03%) DOW
39,112.16 -299.05 (-0.76%) Bitcoin GBP
49,017.63 +1,268.16 (+2.66%)
Intelligent Bio Solutions Inc. (INBS)
After hours:
| Previous close | 1.8800 |
| Open | 1.9300 |
| Bid | 0.0000 x 0 |
| Ask | 1.8200 x 100 |
| Day's range | 1.7700 - 1.9300 |
| 52-week range | 1.7600 - 39.4800 |
| Volume | |
| Avg. volume | 62,790 |
| Market cap | 5.626M |
| Beta (5Y monthly) | 4.76 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and Logistics Sector
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it has successfully signed two new major customer accounts within the UK warehouse and logistics sector within the past three months. These accounts employ more than 15,000 individuals at more than 70 locations and will adopt INBS’ innovative Intelligent Fingerprinting
- GlobeNewswire
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
Pharmacokinetic study is key step on path to expansion into US marketNEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it is entering the next phase of its planned 510(k) submission to the FDA. The Company has successfully completed subject screening for its Pharmacokinetic (PK) Study and will begin dosing and sampling
- GlobeNewswire
Intelligent Bio Solutions Implements Strategic Reorganization Plan to Support Global Growth Initiatives
NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the implementation of a strategic and comprehensive reorganization and productivity plan to support the Company’s global growth initiatives. As the Company approaches several growth initiatives globally, including planned entry into the U.S. market in 2025, management has ma
